The rise of Viagra initially sparked a period of growth for pharma, but recent shifts present a complicated picture for investors. Lower-cost alternatives are eating into earnings, and ongoing litigation add further https://berthatcmm348209.bluxeblog.com/73587900/sildenafil-and-the-pharmaceutical-industry-a-risky-investment